article Open AccessTop 1% cited
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
The Lancet Oncology · 2011 · Vol. 12(2) · pp. 127–136
Christopher M. Nutting✉(Royal Marsden NHS Foundation Trust)James P. Morden(Institute of Cancer Research)Kevin J. Harrington(Institute of Cancer Research)Teresa Guerrero Urbano(Guy's and St Thomas' NHS Foundation Trust)Shreerang Bhide(Royal Marsden Hospital)Catharine H. Clark(Royal Surrey County Hospital)Elizabeth Miles(Mount Vernon Hospital)Aisha Miah(Royal Marsden Hospital)Kate Newbold(Royal Marsden Hospital)Mary Anne Tanay(Royal Marsden Hospital)F. Adab(University Hospitals of North Midlands NHS Trust)Sarah Jefferies(Cambridge University Hospitals NHS Foundation Trust)Christopher Scrase(Ipswich Hospital)B. Yap(The Christie NHS Foundation Trust)Roger A’Hern(Institute of Cancer Research)Mark Sydenham(Institute of Cancer Research)Marie A. Emson(Institute of Cancer Research)Emma Hall(Institute of Cancer Research)
Abstract
Cancer Research UK (CRUK/03/005).
Head and Neck Cancer StudiesAdvanced Radiotherapy TechniquesLung Cancer Diagnosis and TreatmentMedicineHead and neck cancerRadiation therapyHead and neckSurgery
MeSH terms
FemaleHead and Neck NeoplasmsHumansLongitudinal StudiesMaleMiddle AgedNeoplasm StagingParotid GlandXerostomiaRadiotherapy, Intensity-Modulated
Funding
- Cancer Research UK
- National Institute for Health and Care Research
Citations
1,665
FWCI
88.27
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach
Radiotherapy and Oncology · 2013 · 533 citations
Treatment of a first patient with FLASH-radiotherapy
Radiotherapy and Oncology · 2019 · 909 citations
Clinical translation of FLASH radiotherapy: Why and how?
Radiotherapy and Oncology · 2019 · 451 citations
References
Interpreting the significance of changes in health-related quality-of-life scores.
Journal of Clinical Oncology · 1998 · 2,890 citations
Late effects toxicity scoring: the SOMA scale
Radiotherapy and Oncology · 1995 · 390 citations
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
International Journal of Radiation Oncology*Biology*Physics · 1995 · 4,794 citations
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Radiotherapy and Oncology · 2009 · 3,022 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
International Journal of Radiation Oncology*Biology*Physics · 2006 · 744 citations
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
JNCI Journal of the National Cancer Institute · 1993 · 15,705 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.